Physician profile
Uma G Swamy
NPI 1427377431
$6,491.29
in general payments reported to CMS, 2019-2025
65 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what 88% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $96.36 · 2021: $158 · 2022: $855 · 2023: $1,388 · 2024: $1,745 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,776.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $678.35 | 2019-2025 | Darzalex, Rybrevant, Carvykti |
| Novartis Pharmaceuticals Corporation | $643.32 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $630.57 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $353.21 | 2020-2025 | Ninlaro, Iclusig, Fruzaqla |
| Astrazeneca Pharmaceuticals LP | $313.46 | 2021-2025 | Enhertu, Lynparza, Imfinzi |
| Eisai INC. | $295.19 | 2019-2025 | |
| Abbvie INC. | $224.30 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $198.64 | 2023-2024 | Pylarify |
| Daiichi Sankyo INC. | $191.04 | 2019-2025 | Enhertu, Datroway |
| Pfizer INC. | $174.98 | 2019-2025 | |
| Ethicon INC. | $158.57 | 2022 | |
| Seagen INC. | $158.21 | 2022-2023 | Tukysa, Padcev |
| Amgen INC. | $140.87 | 2019-2023 | Lumakras |
| Pharmacosmos Therapeutics INC. | $129.70 | 2023-2025 | Monoferric |
| Pharmacyclics LLC, An Abbvie Company | $98.25 | 2023 | Imbruvica, Epkinly |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Swamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.